75% of CKD patients are chronically under-hydrated at home (NIH National Library of Medicine)
50%+ reduction in UTI recurrence with increased daily fluid intake (JAMA Internal Medicine, 2018)
$16B annual cost of preventable UTI-related hospitalizations in the U.S. (CDC / Journal of Urology)
0 objective tools exist to verify fluid adherence outside a clinical setting Documented clinical gap, 2022
Fluid targets are set according to your doctor's prescription.
Every sip is measured and recorded. Adherence data replaces self-reporting, which clinical literature shows is consistently unreliable.
Intake records are accessible to your care team, enabling real-world monitoring between clinic visits and supporting informed treatment decisions.
A landmark randomized clinical trial found that increasing water intake by 1.5L per day reduced UTI recurrence by more than 50% in pre-menopausal women. Increased daily fluid intake is now a first-line clinical recommendation for UTI prevention. Water.io Care gives physicians the objective intake data to monitor whether patients are meeting their prescribed fluid targets. Source: Hooton TM et al., JAMA Internal Medicine, 2018; European Association of Urology Guidelines on Recurrent UTI
Clinical research shows adequate fluid intake may slow CKD progression and reduce the risk of acute kidney injury. Physicians routinely prescribe specific daily fluid targets, yet patient adherence at home is clinically unverifiable without objective tracking. Water.io Care provides the longitudinal intake record physicians need to assess adherence between visits. Source: Clark WF et al., American Journal of Nephrology / NIH, 2016; National Kidney Foundation Clinical Practice Guidelines
Rome IV criteria — the gold standard for GI disorder classification — recommend increased fluid intake to reduce constipation, symptom flares, and inflammatory triggers in IBS-C and IBD patients. Fluid targets are prescribed but have no objective monitoring mechanism outside a clinical setting. Water.io Care closes that gap. Source: Rome IV Functional GI Disorders Criteria; Rome Foundation, 2016 (updated 2022)
CHF patients require precise fluid management — often restricting to 1.5–2L daily. Exceeding prescribed limits contributes to decompensation and avoidable readmission. Water.io Care gives care teams remote visibility into whether patients are staying within their physician-prescribed fluid range. Source: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure; Circulation 2022;145:e895–e1032
Clinical guidelines recommend specific hydration targets for patients with diabetes to support glycemic regulation and kidney function. Patients with comorbid kidney involvement often carry both minimum and maximum fluid targets. Water.io Care provides the objective intake record needed to verify compliance with physician-prescribed protocols. Source: American Diabetes Association Standards of Medical Care in Diabetes, 2023
ERAS surgical recovery protocols prescribe specific hydration targets to reduce the risk of post-operative complications. Remote verification of adherence to those targets is a documented clinical need across surgical specialties. Water.io Care provides the objective fluid intake record to support monitoring during the recovery period. Source: ERAS Society Guidelines: Perioperative Fluid Management, 2021
Whether you are a clinician evaluating Water.io Care for a patient hydration program, a health system exploring integration, or a researcher interested in fluid adherence technology — we welcome your inquiry.